HopeStage
Back to all studies
CompletedNCT05345977

eMotiph: E-mental Health Solution for Patients With Schizophrenia

Device studyAges 18–55Spain
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Listed locations
Barcelona, SpainSee all locations and recruitment
Activities
Device procedures described in the protocol
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: June 1, 2021
Recruitment status
Completed
Enrollment listed in the registry
7
Sponsor
Grupo Pulso
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
Spain
Age range
From 18 Years to 55 Years
Official registry ID
NCT05345977
Official title
Show the full official title

eMotiph: Smart and Innovative E-mental Health Solution to Manage Patients With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Barcelona

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Grupo Pulso.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me